Ardelyx, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
ARDX on Nasdaq
Industry
Pharmaceutical Preparations
Location
34175 Ardenwood Blvd., Fremont, CA

Insiders trading volume in the past year

Ardelyx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Scott D. Sandell 10%+ Owner $15M Dec 9, 2021
Forest Baskett 10%+ Owner $15M Dec 9, 2021
David M. Mott Director $10.7M +$6.78M +171% Jun 18, 2025
Michael Raab President & CEO, Director $9.93M -$2.25M -18.5% Aug 21, 2025
Susan Rodriguez Chief Commercial Officer $3.84M May 21, 2024
Justin Renz Chief Financial Officer $2.9M -$125K -4.15% Aug 21, 2025
Laura A. Williams Chief Patient Officer $2.61M -$616K -19.1% Aug 26, 2025
David Rosenbaum Chief Development Officer $2.52M -$362K -12.5% Nov 20, 2024
Elizabeth Grammer Chief Legal and Administrative Officer $2.29M -$117K -4.86% Aug 21, 2025
Eric D. Foster Chief Commercial Officer $2.26M -$101K -4.27% Aug 21, 2025
Mike Kelliher Chief Business Officer $2.12M -$91.4K -4.14% Aug 21, 2025
Robert Blanks Chief Regulatory and Quality Affairs Officer $1.84M -$23.7K -1.27% Nov 20, 2024
Richard J. Rodgers Director $1.5M Jun 18, 2025
William C. Bertrand JR Director $1.15M Jun 18, 2025
Jan M. Lundberg Director $1.09M Jun 15, 2023
Jeffrey W. Jacobs Chief Scientific Officer $793K Nov 22, 2021
Robert Ora Felsch SVP Finance and Chief Accounting Officer $722K Aug 20, 2024
Onaiza Cadoret-Manier Director $643K Jun 18, 2025
Muna Bhanji Director $591K Jun 18, 2025
Joseph J. Reilly Officer $554K Nov 15, 2024
Robert B. Bazemore Director $244K Jun 18, 2025
Merdad Parsey Director $207K Jun 18, 2025
Geoffrey A. Block Director $114K Jun 15, 2023

Recent Insider Transactions by Companies or Individuals for Ardelyx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.